A cardiologist conducts a randomized trial with patients to compare a new antihypertensive drug and a placebo. Patients are randomly assigned to the drug group or the placebo group. After weeks, the cardiologist records each patient's systolic blood pressure and computes the reduction from baseline. Which of the following is the response variable in this study?
